Thienylhalomethylketones: Irreversible glycogen synthase kinase 3 inhibitors as useful pharmacological tools
Daniel I. Pérez(Cedars-Sinai Medical Center), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), F. Javier Luque(Universidad Complutense de Madrid), Carmen Gil(Instituto de Salud Carlos III), Francisco Wandosell(Consejo Superior de Investigaciones Científicas), Santiago Conde(Consejo Superior de Investigaciones Científicas), Josep Lluis Gelpí(Barcelona Supercomputing Center), Francisco J. Moreno(Instituto de Química Médica), Concepción Pérez(Instituto de Química Médica), Diana Simón
Cited by 57
Related Papers
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k
Non-coding recurrent mutations in chronic lymphocytic leukaemia
|Nature|2015|851
Molecular dynamics simulations: advances and applications
|Advances and Applications in Bioinformatics and Chemistry|2015|812
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469